BRAF and melanoma: Although the baseline level of TAZ protein did not predict the response to BRAF inhibitors in a panel of BRAFV600E melanoma cell lines, ectopic overexpression increased resistance in several BRAFV600E melanoma cell lines (Fig. S4A, B).